{
    "clinical_study": {
        "@rank": "36777", 
        "arm_group": [
            {
                "arm_group_label": "Arm 1: Skin closure with suture", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects in this group will be randomized to suture for skin closure with computer generated random card draw."
            }, 
            {
                "arm_group_label": "Arm 2: Skin closure with staples", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects randomized to skin closure with staples with computer generated random card draw."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a randomized prospective clinical trial designed to determine the wound complication\n      rates for stainless steel staples versus subcuticular suture for skin closure in the obese\n      parturient (BMI\u2265 30kg/m2) undergoing cesarean delivery."
        }, 
        "brief_title": "Sutures vs. Staples Skin Closure After C-section in Obese Patients", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Obesity", 
            "Pregnancy"
        ], 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  18 years or older\n\n          -  BMI \u2265 30kg/m2 on admission to labor and delivery\n\n          -  Patient is for scheduled cesarean delivery or in non-emergent labor but has an\n             indication for cesarean delivery\n\n          -  Singleton pregnancies\n\n          -  Gestational age \u2265 24weeks\n\n          -  Cesarean delivery performed under regional anesthesia\n\n        Exclusion criteria:\n\n          -  Refusal to participate\n\n          -  BMI < 30kg/m2\n\n          -  < 24 weeks gestation\n\n          -  Intrauterine fetal demise\n\n          -  Chronic pain syndrome requiring chronic narcotic use\n\n          -  Emergent clinical situations which preclude obtaining informed consent"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "2250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01820221", 
            "org_study_id": "138350"
        }, 
        "intervention": {
            "arm_group_label": [
                "Arm 1: Skin closure with suture", 
                "Arm 2: Skin closure with staples"
            ], 
            "description": "Random card draw to either suture skin closure or staple skin closure arm of study.", 
            "intervention_name": "Suture vs. staples closure method after c-section in obese women.", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "cesarean delivery", 
            "wound complications", 
            "skin closure methods"
        ], 
        "lastchanged_date": "April 25, 2014", 
        "location": {
            "contact": {
                "email": "dgeastham@uams.edu", 
                "last_name": "Donna G Eastham, BA", 
                "phone": "501-526-7630"
            }, 
            "facility": {
                "address": {
                    "city": "Little Rock", 
                    "country": "United States", 
                    "state": "Arkansas", 
                    "zip": "72205"
                }, 
                "name": "University of Arkansas for Medical Sciences"
            }, 
            "investigator": {
                "last_name": "Imelda N Odibo, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Staples Compared With Subcuticular Suture for Skin Closure After Cesarean Delivery in Obese Patients", 
        "overall_contact": {
            "email": "inodibo@uams.edu", 
            "last_name": "Imelda N Odibo, MD", 
            "phone": "501-686-8345"
        }, 
        "overall_contact_backup": {
            "email": "efmagann@uams.edu", 
            "last_name": "Everett F Magann, MD", 
            "phone": "501-686-8345"
        }, 
        "overall_official": {
            "affiliation": "University of Arkansas", 
            "last_name": "Imelda N Odibo, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "USA:University of Arkansas for Medical Sciences IRB", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Wound complications will be classified as minor and major and the major complications will be further stratified as Seroma, Hematoma and Wound Infection/Surgical site infection (SSI).\nMinor wound disruption: any wound disruption that DOES not require that the incision be opened, evacuated, irrigated or debrided. There is no evidence of infection including erythema, induration or purulent material. No antibiotic therapy is given.\nMajor wound disruption requires that incision be opened, evacuated, and or irrigated or debrided and includes:\nSeroma: collection of serous fluid in the wound without evidence of infection\nHematoma: Demonstrable blood clot between the rectus fascia and the skin\nInfection: Any wound that drains purulent material and shows at least 2 of the classic signs of infection; induration, erythema, tenderness, fever. Wound infections will be further classified as superficial or deep.", 
            "measure": "Wound complication rates", 
            "safety_issue": "No", 
            "time_frame": "6 weeks postpartum"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01820221"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "To allow for adequate monitoring and assessment of postoperative pain, standardized postoperative pain analgesia protocol at our institution will be followed. This comprises of non-steroidal anti- inflammatory drugs and Narcotics as needed. Patients will be asked to complete a visual analog pain scale ranging from 0-10 on postoperative day 2. Information on use of pain medication during hospitalization and frequency will also be collected from the medical record.", 
            "measure": "Post-operative pain", 
            "safety_issue": "No", 
            "time_frame": "72 hours postpartum"
        }, 
        "source": "University of Arkansas", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Arkansas", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}